SECORZIO Trademark
Trademark Overview
On Monday, February 3, 2025, a trademark application was filed for SECORZIO with the United States Patent and Trademark Office. The USPTO has given the SECORZIO trademark a serial number of 99026763. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, July 31, 2025. This trademark is owned by Merck Sharp & Dohme B.V.. The SECORZIO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations
General Information
Serial Number | 99026763 |
Word Mark | SECORZIO |
Filing Date | Monday, February 3, 2025 |
Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
Status Date | Thursday, July 31, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, August 19, 2025 |
Trademark Statements
Goods and Services | Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, February 3, 2025 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Merck Sharp & Dohme B.V. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 26 - NOT AVAILABLE |
Address | Haarlem 2031 BN NL |
Trademark Events
Event Date | Event Description |
Monday, February 3, 2025 | NEW APPLICATION ENTERED |
Monday, February 3, 2025 | APPLICATION FILING RECEIPT MAILED |
Monday, February 3, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, April 9, 2025 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
Wednesday, April 9, 2025 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Friday, July 11, 2025 | ASSIGNED TO EXAMINER |
Tuesday, July 15, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |